Symbols / BDSX Stock $11.58 -9.88% Biodesix, Inc.

Healthcare • Diagnostics & Research • United States • NGM
BDSX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Stock Fundamentals
Scroll to Statements
Market Cap 117.04M Enterprise Value 170.20M Income -35.27M Sales 88.50M Book/sh -0.30 Cash/sh 1.93
Dividend Yield — Payout 0.00% Employees 334 IPO — P/E — Forward P/E -52.64
PEG — P/S 1.32 P/B -38.73 P/C — EV/EBITDA -7.70 EV/Sales 1.92
Quick Ratio 1.61 Current Ratio 1.86 Debt/Eq — LT Debt/Eq — EPS (ttm) -4.67 EPS next Y -0.22
EPS Growth — Revenue Growth 40.80% Earnings 2026-05-04 ROA -18.79% ROE -3.83% ROIC —
Gross Margin 81.11% Oper. Margin -6.84% Profit Margin -39.85% Shs Outstand 10.11M Shs Float 5.95M Short Float 3.22%
Short Ratio 1.46 Short Interest — 52W High 20.21 52W Low 3.44 Beta 0.57 Avg Volume 124.48K
Volume 125.39K Target Price $30.00 Recom Strong_buy Prev Close $12.85 Price $11.58 Change -9.88%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$30.00
Mean price target
2. Current target
$11.58
Latest analyst target
3. DCF / Fair value
$-21.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.58
Low
$20.00
High
$40.00
Mean
$30.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-27 up William Blair Market Perform → Outperform —
2026-02-17 main Canaccord Genuity Buy → Buy $20
2025-09-19 main Canaccord Genuity Buy → Buy $20
2025-05-21 main Scotiabank Sector Outperform → Sector Outperform $2
2025-05-14 main Craig-Hallum Buy → Buy $2
2025-05-14 main Lake Street Buy → Buy $2
2025-05-14 main Canaccord Genuity Buy → Buy $2
2025-05-14 down William Blair Outperform → Market Perform —
2025-04-29 main Canaccord Genuity Buy → Buy $3
2024-09-16 init Scotiabank — → Sector Outperform $3
2024-07-26 init Craig-Hallum — → Buy $3
2024-05-13 init TD Cowen — → Buy $3
2024-05-03 init Lake Street — → Buy $3
2024-03-04 reit Canaccord Genuity Buy → Buy $4
2023-12-07 reit Canaccord Genuity Buy → Buy $4
2022-05-12 main Morgan Stanley — → Equal-Weight $5
2022-04-20 init Cowen & Co. — → Outperform —
2021-11-17 down Morgan Stanley Overweight → Equal-Weight $11
2021-05-12 main Morgan Stanley — → Overweight $23
2021-03-18 main Morgan Stanley — → Overweight $25
News
RSS: Latest BDSX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 PATIENCE JOHN Chairman of the Board — 1,361 — —
2026-02-23 O'KANE KIERAN Officer — 535 $12.78 $6,835
2026-02-23 COWIE ROBIN HARPER Chief Financial Officer — 535 $12.78 $6,835
2026-02-23 PESTANO GARY ANTHONY Officer — 556 $12.78 $7,103
2026-02-23 HUTTON SCOTT Chief Executive Officer — 1,490 $12.78 $19,036
2026-02-23 VAZQUEZ CHRISTOPHER Officer — 211 $12.78 $2,696
2026-02-20 O'KANE KIERAN Officer — 1,469 — —
2026-02-20 COWIE ROBIN HARPER Chief Financial Officer — 1,469 — —
2026-02-20 PESTANO GARY ANTHONY Officer — 1,528 — —
2026-02-20 HUTTON SCOTT Chief Executive Officer — 4,844 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
88.50
+24.08%
71.32
+45.30%
49.09
+28.46%
38.21
Operating Revenue
88.50
+24.08%
71.32
+45.30%
49.09
+28.46%
38.21
Cost Of Revenue
16.72
+7.36%
15.57
+19.70%
13.01
-8.08%
14.15
Reconciled Cost Of Revenue
16.72
+7.36%
15.57
+19.70%
13.01
-8.08%
14.15
Gross Profit
71.78
+28.75%
55.75
+54.53%
36.08
+49.96%
24.06
Operating Expense
99.55
+10.59%
90.01
+16.33%
77.38
+3.77%
74.56
Research And Development
12.00
+25.55%
9.56
-4.30%
9.99
-23.77%
13.10
Selling General And Administration
87.55
+8.82%
80.45
+19.39%
67.39
+9.64%
61.46
Selling And Marketing Expense
—
—
—
61.46
Total Expenses
116.27
+10.12%
105.58
+16.81%
90.39
+1.88%
88.72
Operating Income
-27.77
+18.96%
-34.26
+17.04%
-41.30
+18.23%
-50.51
Total Operating Income As Reported
-27.87
+19.20%
-34.50
+16.55%
-41.34
+18.28%
-50.59
EBITDA
-21.95
+24.88%
-29.22
+21.25%
-37.10
+28.00%
-51.53
Normalized EBITDA
-21.56
+24.96%
-28.73
+19.71%
-35.78
+19.68%
-44.55
Reconciled Depreciation
5.60
+2.66%
5.46
-0.93%
5.51
-5.77%
5.84
EBIT
-27.55
+20.55%
-34.67
+18.63%
-42.61
+25.73%
-57.38
Total Unusual Items
-0.39
+20.37%
-0.49
+63.13%
-1.32
+81.11%
-6.98
Total Unusual Items Excluding Goodwill
-0.39
+20.37%
-0.49
+63.13%
-1.32
+81.11%
-6.98
Special Income Charges
-0.11
+77.98%
-0.49
-1004.55%
-0.04
+99.38%
-7.06
Other Special Charges
—
0.25
—
6.98
Impairment Of Capital Assets
0.11
-55.04%
0.24
+440.91%
0.04
-45.68%
0.08
Restructuring And Mergern Acquisition
—
—
—
0.00
Net Income
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Pretax Income
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Net Non Operating Interest Income Expense
-7.72
+6.56%
-8.26
+13.40%
-9.54
-18.14%
-8.07
Interest Expense Non Operating
7.72
-6.56%
8.26
-13.40%
9.54
+18.14%
8.07
Net Interest Income
-7.72
+6.56%
-8.26
+13.40%
-9.54
-18.14%
-8.07
Interest Expense
7.72
-6.56%
8.26
-13.40%
9.54
+18.14%
8.07
Other Income Expense
0.22
+152.54%
-0.41
+68.52%
-1.31
+80.90%
-6.87
Other Non Operating Income Expenses
0.60
+727.40%
0.07
+1116.67%
0.01
-94.50%
0.11
Gain On Sale Of Security
-0.28
—
-1.27
-1616.67%
0.08
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Net Income From Continuing Operation Net Minority Interest
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Net Income From Continuing And Discontinued Operation
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Net Income Continuous Operations
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Normalized Income
-34.88
+17.83%
-42.45
+16.49%
-50.83
+13.07%
-58.47
Net Income Common Stockholders
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Diluted EPS
—
-6.60
+48.44%
-12.80
+58.71%
-31.00
Basic EPS
—
-6.60
+48.44%
-12.80
+58.71%
-31.00
Basic Average Shares
—
6.48
+57.92%
4.11
+95.03%
2.11
Diluted Average Shares
—
6.48
+57.92%
4.11
+95.03%
2.11
Diluted NI Availto Com Stockholders
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Line Item Trend 2023-12-31
Total Assets
99.10
Current Assets
39.68
Cash Cash Equivalents And Short Term Investments
26.28
Cash And Cash Equivalents
26.28
Receivables
7.68
Accounts Receivable
7.68
Gross Accounts Receivable
7.74
Allowance For Doubtful Accounts Receivable
-0.07
Other Current Assets
5.72
Total Non Current Assets
59.41
Net PPE
29.61
Gross PPE
35.22
Accumulated Depreciation
-5.61
Properties
0.00
Machinery Furniture Equipment
2.68
Construction In Progress
0.00
Other Properties
7.83
Leases
24.71
Goodwill And Other Intangible Assets
22.94
Goodwill
15.03
Other Intangible Assets
7.91
Other Non Current Assets
6.86
Total Liabilities Net Minority Interest
94.52
Current Liabilities
33.42
Payables And Accrued Expenses
6.78
Payables
2.93
Accounts Payable
2.93
Current Accrued Expenses
3.85
Pensionand Other Post Retirement Benefit Plans Current
3.85
Current Debt And Capital Lease Obligation
0.30
Current Debt
0.05
Other Current Borrowings
0.05
Current Capital Lease Obligation
0.25
Current Deferred Liabilities
0.32
Current Deferred Revenue
0.32
Other Current Liabilities
22.15
Total Non Current Liabilities Net Minority Interest
61.10
Long Term Debt And Capital Lease Obligation
60.39
Long Term Debt
35.23
Long Term Capital Lease Obligation
25.16
Other Non Current Liabilities
0.71
Stockholders Equity
4.58
Common Stock Equity
4.58
Capital Stock
0.10
Common Stock
0.10
Preferred Stock
0.00
Share Issued
4.81
Ordinary Shares Number
4.81
Treasury Shares Number
0.00
Additional Paid In Capital
424.05
Retained Earnings
-419.57
Total Equity Gross Minority Interest
4.58
Total Capitalization
39.80
Working Capital
6.27
Invested Capital
39.86
Total Debt
60.69
Net Debt
8.99
Capital Lease Obligations
25.41
Net Tangible Assets
-18.36
Tangible Book Value
-18.36
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-23.27
+52.17%
-48.65
-112.72%
-22.87
+49.15%
-44.97
Cash Flow From Continuing Operating Activities
-23.27
+52.17%
-48.65
-112.72%
-22.87
+49.15%
-44.97
Net Income From Continuing Operations
-35.27
+17.86%
-42.93
+17.67%
-52.15
+20.32%
-65.45
Depreciation Amortization Depletion
5.60
+2.66%
5.46
-0.93%
5.51
-5.77%
5.84
Depreciation
5.60
+2.66%
5.46
-0.93%
5.51
-5.77%
5.84
Depreciation And Amortization
5.60
+2.66%
5.46
-0.93%
5.51
-5.77%
5.84
Other Non Cash Items
1.35
-45.53%
2.48
-89.47%
23.60
+180.48%
8.41
Stock Based Compensation
4.14
-37.65%
6.64
+23.54%
5.37
-9.86%
5.96
Provisionand Write Offof Assets
0.18
-79.71%
0.89
+78.47%
0.50
+434.41%
0.09
Asset Impairment Charge
0.11
-55.04%
0.24
+440.91%
0.04
-45.68%
0.08
Operating Gains Losses
0.28
+12.90%
0.25
-80.53%
1.27
-81.53%
6.90
Gain Loss On Investment Securities
0.28
—
1.27
+1616.67%
-0.08
Change In Working Capital
0.33
+101.54%
-21.67
-208.72%
-7.02
-2.99%
-6.82
Change In Receivables
-0.53
+70.68%
-1.81
+61.62%
-4.72
-214.32%
-1.50
Changes In Account Receivables
-0.53
+70.68%
-1.81
+61.62%
-4.72
-214.32%
-1.50
Change In Payables And Accrued Expense
1.86
+13.56%
1.64
+219.10%
0.51
+166.36%
-0.77
Change In Other Working Capital
0.17
-29.84%
0.25
+132.85%
-0.76
+37.76%
-1.21
Change In Other Current Assets
-0.38
-148.34%
0.78
-16.42%
0.94
+139.23%
-2.39
Change In Other Current Liabilities
-0.79
+96.50%
-22.53
-651.65%
-3.00
-219.85%
-0.94
Investing Cash Flow
-0.40
+88.28%
-3.44
+85.08%
-23.06
-552.57%
-3.53
Cash Flow From Continuing Investing Activities
-0.40
+88.28%
-3.44
+85.08%
-23.06
-552.57%
-3.53
Net PPE Purchase And Sale
-0.26
+91.98%
-3.23
+85.91%
-22.92
-594.94%
-3.30
Purchase Of PPE
-0.26
+91.98%
-3.23
+85.91%
-22.92
-594.94%
-3.30
Capital Expenditure
-0.40
+88.28%
-3.44
+85.08%
-23.06
-552.57%
-3.53
Net Business Purchase And Sale
—
—
—
—
Purchase Of Business
—
—
—
—
Net Intangibles Purchase And Sale
-0.14
+31.43%
-0.21
-46.85%
-0.14
+39.41%
-0.24
Purchase Of Intangibles
-0.14
+31.43%
-0.21
-46.85%
-0.14
+39.41%
-0.24
Financing Cash Flow
16.42
-68.46%
52.05
+78.69%
29.13
-50.53%
58.88
Cash Flow From Continuing Financing Activities
16.42
-68.46%
52.05
+78.69%
29.13
-50.53%
58.88
Net Issuance Payments Of Debt
9.98
+19666.67%
-0.05
-100.51%
9.95
-39.68%
16.50
Issuance Of Debt
10.00
0.00
-100.00%
10.00
-77.83%
45.10
Repayment Of Debt
-0.02
+58.82%
-0.05
-4.08%
-0.05
+99.83%
-28.60
Long Term Debt Issuance
10.00
0.00
-100.00%
10.00
-77.83%
45.10
Long Term Debt Payments
-0.02
+58.82%
-0.05
-4.08%
-0.05
+99.83%
-28.60
Net Long Term Debt Issuance
9.98
+19666.67%
-0.05
-100.51%
9.95
-39.68%
16.50
Net Common Stock Issuance
7.32
-86.84%
55.62
+97.77%
28.13
-52.76%
59.54
Proceeds From Stock Option Exercised
0.50
-23.54%
0.65
-11.44%
0.73
+17.63%
0.62
Net Other Financing Charges
-1.38
+66.96%
-4.17
+56.89%
-9.68
+45.54%
-17.78
Changes In Cash
-7.26
-18507.69%
-0.04
+99.77%
-16.80
-261.94%
10.38
Beginning Cash Position
26.33
-0.15%
26.37
-38.92%
43.17
+31.64%
32.80
End Cash Position
19.07
-27.56%
26.33
-0.15%
26.37
-38.92%
43.17
Free Cash Flow
-23.67
+54.55%
-52.09
-13.40%
-45.93
+5.31%
-48.51
Interest Paid Supplemental Data
6.40
-8.91%
7.02
+75.86%
3.99
+295.84%
1.01
Income Tax Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
7.32
-86.84%
55.62
+97.77%
28.13
-52.76%
59.54
Issuance Of Capital Stock
7.32
-86.84%
55.62
+97.77%
28.13
-52.76%
59.54
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category